EGFR mutation mediates resistance to EGFR tyrosine kinase inhibitors in NSCLC: From molecular mechanisms to clinical research
Publication date: May 2021Source: Pharmacological Research, Volume 167Author(s): Rui-Fang Dong, Miao-Lin Zhu, Ming-Ming Liu, Yi-Ting Xu, Liu-Liu Yuan, Jing Bian, Yuan-Zheng Xia, Ling-Yi Kong
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Non-Small Cell Lung Cancer